Browse Title Index


 
Issue Title
 
Vol 1, No 4 (2005): September/October Methadone-related deaths Abstract   PDF
Lynn R. Webster, MD
 
Vol 5, No 6 (2009): November/December Methylnaltrexone potentiates body weight and fat reduction with leptin Abstract
Chun-Su Yuan, MD, PhD, Shi Sun, PhD, Anoja Attele, MD, Chong-Zhi Wang, PhD, Robin Tong, BS, Robert J. Israel, MD
 
Vol 5, No 4 (2009): July/August Methylnaltrexone reduced body weight gain in ob/ob mice Abstract
Chun-Su Yuan, MD, PhD, Chong-Zhi Wang, PhD, Anoja Attele, MD, Liu Zhang, PhD
 
Vol 5, No 4 (2009): July/August Midazolam as an antiemetic in patients receiving epidural morphine for postoperative pain relief Abstract
Mokhtar Elhakim, MD, Hany Abd Elfattah, MD, Dalia Nasr El-Din, MD, Reem El-Kabarity, MD, Azia Atef, MD, Atef El-Fakey, MD
 
Vol 12, No 1 (2016): January/February Minimizing stress with remifentanil in a patient with Takotsubo undergoing ophthalmic surgery Abstract
Sbaraglia Fabio, MD, Garra Rossella, MD, De Riso Mariella, MD, Continolo Nicola, MD, Sammartino Maria, MD
 
Vol 2, No 3 (2006): May/June Modafinil: Is it ready for prime time? Abstract   PDF
Eric Prommer, MD
 
Vol 1, No 5 (2005): November/December Monitoring outcomes during long-term opioid therapy for noncancer pain: Results with the Pain Assessment and Documentation Tool Abstract   PDF
Steven D. Passik, PhD, Kenneth L. Kirsh, PhD, Laurie Whitcomb, MA, Jeffrey R. Schein, PhD, MPH, Mitchell A. Kaplan, PhD, Sheri L. Dodd, MSc, Leah Kleinman, PhD, Nathaniel P. Katz, MD, Russell K. Portenoy, MD
 
Vol 10, No 1 (2014): January/February Monitoring oxycodone use in patients with chronic pain: Analysis of oxycodone and metabolite excretion in saliva and urine Abstract
Kathleen V. Moy, MS, Joseph D. Ma, PharmD, Candis M. Morello, PharmD, CDE, Rabia S. Atayee, PharmD, BCPS, Brookie M. Best, PharmD, MAS
 
Vol 17, No 4 (2021): July/August More than half of opioids prescribed to pediatric patients after ambulatory knee surgery are unused Abstract
Pamela Wendel, MD, Danya DeMeo, BS, Madison R. Heath, BS, Alexandra T. Mackie, BA, PB-BS, Haoyan Zhong, MPA, Kathryn DelPizzo, MD, Kanupriya Kumar, MD, Peter D. Fabricant, MD, MPH
 
Vol 1, No 2 (2005): May/June Morphine analgesia in cancer pain: Role of the glucuronides Abstract   PDF
Richard T. Penson, MRCP, MD, Simon P. Joel, PhD, Anna Gloyne, BSc, Simon Clark, BSc, Maurice L. Slevin, FRCP, MD
 
Vol 7, No 2 (2011): March/April Morphine and cancer progression: Hydrogen peroxide points to need for more research Abstract
Herbert Bosshart, MD
 
Vol 8, No 4 (2012): July/August Morphine clearance in children: Does race or genetics matter? Abstract
Senthilkumar Sadhasivam, MD, MPH, Elke H. J. Krekels, MSc, Vidya Chidambaran, MD, Hope R. Esslinger, MPT, Pornswan Ngamprasertwong, MD, Kejian Zhang, MD, MBA, Tsuyoshi Fukuda, PhD, Alexander A. Vinks, PharmD, PhD
 
Vol 3, No 1 (2007): January/February Morphine prescription in end-of-life care and euthanasia: French home nurses’ opinions Abstract   PDF
Marc Karim Bendiane, PhDc, Anne-Deborah Bouhnik, PhDc, Roger Favre, PhD, Anne Galinier, MD, Yolande Obadia, MD, Jean-Paul Moatti, PhD, Patrick Peretti-Watel, PhD
 
Vol 1, No 1 (2005): March/April Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians’ attitudes Abstract   PDF
Marc K. Bendiane, MSC, Patrick Peretti-Watel, PhD, Herve Pegliasco, MD, Roger Favre, PhD, Anne Galinier, MD, Jean-Marc Lapiana, MD, Yolande Obadia, MD
 
Vol 2, No 3 (2006): May/June Morphine toxicity in renal failure Abstract   PDF
Ferraz Gonçalves, MD
 
Vol 10, No 5 (2014): September/October MT-45: A new, dangerous legal high Abstract
Maurizio Coppola, MD, Raffaella Mondola, MD
 
Vol 17, No 5 (2021): September/October Multimodal opioid sparing onco-anesthesia: A consensus practice guideline from Society of Onco-Anesthesia and Perioperative Care (SOAPC) Abstract
Sohan Lal Solanki, MD, PDCC, MAMS, Raghu S. Thota, MD, MAMS, Jeson Rajan Doctor, MD, DNB, MNAMS, Gauri Raman Gangakhedkar, DNB, Parmanand Jain, MD, MAMS, Vijaya Gottumukkala, MD, Rakesh Garg, MD, Juan P. Cata, MD, Jyotsna Goswami, MD, Namrata Ranganath, MD, Seshadri Ramkiran, DA, DNB, Babita Ghai, MD, Keyuri U. Popat, MD, Donal J. Buggy, MD, Anjali A. Pingle, DNB, FRCA, Vaibhavi Baxi, DNB, Basanth Kumar Rayani, MD, Mary Thomas, DA, DNB, Sushma Bhatnagar, MD, Jigeeshu V. Divatia, MD, FCCM
 
Vol 16, No 6 (2020): November/December Narcotic use in patients following a traumatic injury Abstract
Audis Bethea, PharmD, BCPS, BCCCP, Damayanti Samanta, MS, Kellie Amodeo, MD
 
Vol 16, No 3 (2020): May/June National gender differences in the prescribing of opioid medications from 2006 to 2015 Abstract
Salena Marie Preciado, MS, Daniel Tomaszewski, PharmD, PhD, T. Craig Cheetham, PharmD, MS, Tania Gregorian, PharmD, Sharon Xavioer, PharmD, BCACP, Souhiela Fawaz, BPharm (Hons), PhD
 
Vol 5, No 1 (2009): January/February Nebulized morphine for analgesia in an emergency setting Abstract
Vincent Bounes, MD, Jean Louis Ducassé, MD, Annie Momo Bona, MD, Florent Battefort, MD, Charles-Henri Houze-Cerfon, MD, Dominique Lauque, MD
 
Vol 6, No 6 (2010): November/December Neonatal abstinence scores in opioid-exposed and nonexposed neonates: A blinded comparison Abstract
Hendrée E. Jones, PhD, Cheryl Harrow, RN-LRN, MS, FNP-BC, IBCLC, Kevin E. O’Grady, PhD, Michael Crocetti, MD, Lauren M. Jansson, MD, Karol Kaltenbach, PhD
 
Vol 1, No 1 (2005): March/April News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 2 (2005): May/June News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 3 (2005): July/August News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 4 (2005): September/October News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 5 (2005): November/December News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 1 (2006): January/February News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 2 (2006): March/April News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 1 (2007): January/February News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 2 (2007): March/April News Briefs Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 3 (2005): July/August No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery Abstract   PDF
Enno Freye, MD, PhD, Erhard Hartung, MD, Joseph Victor Levy, PhD
 
Vol 1, No 3 (2005): July/August Novel Aspects of Pain Management: Opioids and Beyond Abstract   PDF
Robert L. Barkin, PharmD, MBA, FCP, DAPPM
 
Vol 12, No 4 (2016): July/August Novel peer review method for improving controlled substance prescribing in primary care Abstract
Brian Penti, MD, MS, Jane M. Liebschutz, MD, MPH, FACP, Brian Kopcza, PharmD, BCACP, Ziming Xuan, ScD, Christine Odell, MD, MSc, Robert Saper, MD, MPH
 
Vol 1, No 5 (2005): November/December November/December 2005 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 6 (2006): November/December NOVEMBER/DECEMBER 2006 Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 6 (2007): November/December November/December 2007 Abstract
Richard A. DeVito, Jr.
 
Vol 4, No 6 (2008): November/December November/December 2008 Abstract
Richard A. DeVito, Jr.
 
Vol 5, No 6 (2009): November/December November/December 2009 Abstract
Richard A. DeVito, Jr.
 
Vol 6, No 6 (2010): November/December NOVEMBER/DECEMBER 2010 Abstract
Richard A. DeVito, Jr.
 
Vol 7, No 6 (2011): November/December November/December 2011 Abstract
Richard A. DeVito, Jr.
 
Vol 10, No 2 (2014): March/April Observation of improved adherence with frequent urine drug testing in patients with pain Abstract
David A. Yee, BS, Michelle M. Hughes, BA, Alexander Y. Guo, MS, Neveen H. Barakat, BS, Stephanie A. Tse, BS, Joseph D. Ma, PharmD, Brookie M. Best, PharmD, MAS, Rabia S. Atayee, PharmD, BCPS
 
Vol 6, No 4 (2010): July/August Observations of medication compliance by measurement of urinary drug concentrations in a pain management population Abstract
Robert West, MS, Amadeo Pesce, PhD, DABCC, Cameron West, PhD, Bridgit Crews, PhD, Charles Mikel, PhD, Murray Rosenthal, DO, FAPA, Perla Almazan, CLS, MT (ASCP), Sergey Latyshev, MS
 
Vol 10, No 3 (2014): May/June Observations on hydrocodone and its metabolites in oral fluid specimens of the pain population: Comparison with urine Abstract
Jennifer M. Cao, BS, Joseph D. Ma, PharmD, Candis M. Morello, PharmD, CDE, Rabia S. Atayee, PharmD, BCPS, Brookie M. Best, PharmD, MAS
 
Vol 8, No 3 (2012): May/June Older adults’ postoperative pain medication usage after total knee arthroplasty: A qualitative descriptive study Abstract
Samantha Bremner, MSc, Fiona Webster, PhD, Joel Katz, PhD, Judy Watt-Watson, PhD, Colin McCartney, MBChB
 
Vol 4, No 5 (2008): September/October Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain Abstract
Adrian Sarbu, MD, Florin Radulescu, MD, Sybil Robertson, BScN, Sylvie Bouchard, MD, PhD
 
Vol 9, No 1 (2013): January/February Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain Abstract
Srinivas Nalamachu, MD, Donna Ruck, ARNP, Rahul Nalamasu, Sam Fasbinder, Ritvik Bansal
 
Vol 17, No 4 (2021): July/August Opiate prescribing patterns in the adolescent population following anterior cruciate ligament reconstruction Abstract
Alexander Karius, BS, Eli M. Cahan, BBA, Nicole A. Segovia, BS, Austin Fan, BA, Charles M. Chan, MD
 
Vol 1, No 3 (2005): July/August Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program Abstract   PDF
Michelle McKenzie, MPH, Grace Macalino, PhD, Clair McClung, BS, David C. Shield, BS, Josiah D. Rich, MD, MPH
 
Vol 3, No 4 (2007): July/August Opiates and opioids: What a difference a name makes Details
Gary M. Reisfield, MD, Roger L. Bertholf, PhD, George R. Wilson, MD
 
Vol 3, No 1 (2007): January/February Opioid administration for acute abdominal pain in the pediatric emergency department Abstract   PDF
Adi Klein-Kremer, MD, Ran D. Goldman, MD
 
Vol 14, No 4 (2018): July/August Opioid analgesics prescription in people with and without cancer in France Abstract
Asmaa Janah, PhD Candidate, Anne-Déborah Bouhnik, PhD, Sébastien Cortaredona, MSc, Julien Mancini, MD, PhD, Philippe Jean Bousquet, MD, PhD, Patrick Peretti-Watel, PhD, Marc-Karim Bendiane, MSc
 
Vol 1, No 4 (2005): September/October Opioid contract use is associated with physician training level and practice specialty Abstract   PDF
Bryan Keith Touchet, MD, William Robert Yates, MD, Kim Annette Coon, EdD
 
Vol 7, No 1 (2011): January/February Opioid delivery in the treatment of cancer breakthrough pain: A review of routes of administration Abstract
Bruce Nicholson, MD, Sanjiv S. Agarwala, MD
 
Vol 16, No 1 (2020): January/February Opioid dispensation among systemic lupus erythematosus patients who persistently frequent the emergency department Abstract
Jiha Lee, MD, MHS, Lisa Gale Suter, MD, Liana Fraenkel, MD, MPH
 
Vol 17, No 1 (2021): January/February Opioid epidemics during the pandemic: Further insights to the same story Abstract
Amany E. Ayad, MD, FIPP
 
Vol 15, No 2 (2019): March/April Opioid e-prescribing trends at discharge in a large pediatric health system Abstract
Christopher M. Horvat, MD, MHA, Brian Martin, DMD, Liwen Wu, MS, Anthony Fabio, PhD, Phil E. Empey, PharmD, PhD, Fanuel Hagos, PhD, Sheila Bigelow, DO, Sajel Kantawala, BS, Alicia K. Au, MD MS, Patrick M. Kochanek, MD, Robert S. B. Clark, MD
 
Vol 13, No 3 (2017): May/June Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease Abstract
Amy Mager, PA-C, MPAS, Kristin Pelot, MSSW, Kathryn Koch, APNP, Lawrence Miller, PsyD, Collin Hubler, BS, Anisah Ndifor, BS, Canice Coan, PharmD, Cynthia Leonard, MSN, Joshua J. Field, MD, MS
 
Vol 1, No 1 (2005): March/April Opioid management: Addressing the gap in understanding, education, and practice Abstract   PDF
Robert E. Enck, MD
 
Vol 15, No 3 (2019): May/June Opioid overdose history and awareness of naloxone in patients seeking outpatient detoxification Abstract
Saurabh B. Bhardwaj, MD, Gerald Cochran, PhD, Julie Kmiec, DO
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Opioid overdose protection: An inevitable need to address an alarming epidemic Abstract
Beatrice Setnik, PhD
 
Vol 16, No 2 (2020): March/April Opioid overdoses: Emerging clinical challenges Abstract
Andrea Ramos, BSN, RN, MSPH, Lina Sarmiento, RN, Noella Dietz, PhD, Nelson Cordero, MD, Ximena Levy, MD-MPH, Charles H. Hennekens, MD, DrPH
 
Vol 9, No 6 (2013): November/December Opioid overuse pain syndrome (OOPS): The story of opioids, Prometheus unbound Abstract
Anand W. Mehendale, MD, Mark P. Goldman, PhD, Rachel P. Mehendale, BA
 
Vol 13, No 2 (2017): March/April Opioid pain medication prescriptions obtained through emergency medical visits in the Veterans Health Administration Abstract
Michael A. Grasso, MD, PhD, FACP, Zachary D. W. Dezman, MD, MS, Clare T. Grasso, PhD Candidate in Computer Science, David A. Jerrard, MD
 
Vol 9, No 3 (2013): May/June Opioid prescribing knowledge and practices: Provider survey following promulgation of guidelines–Utah, 2011 Abstract
Christina A. Porucznik, PhD, MSPH, Erin M. Johnson, MPH, Robert T. Rolfs, MD, MPH, Brian C. Sauer, PhD
 
Vol 17, No 1 (2021): January/February Opioid prescribing trends: Changes after focused hospital resident education and after subsequent adoption of new state regulations Abstract
Victoria Simmons, MD, Sejul Chaudhary, MD, Karen Hagglund, MS, R. David Hayward, PhD, Elango Edhayan, MD
 
Vol 17, No 2 (2021): March/April Opioid prescription claims among women aged 15-44 years—United States, 2013-2017 Abstract
April D. Summers, MPH, Elizabeth C. Ailes, PhD, Michele K. Bohm, MPH, Emmy L. Tran, PharmD, MPH, Cheryl S. Broussard, PhD, Meghan T. Frey, MPH, Suzanne M. Gilboa, PhD, Jean Y. Ko, PhD, Jennifer N. Lind, PharmD, MPH, Margaret A. Honein, PhD
 
Vol 15, No 6 (2019): November/December Opioid prescription patterns among patients with fibromyalgia Abstract
Caio V. M. Sarmento, PT, PhD, Mehrdad Maz, MD, Taylor Pfeifer, DPT, Marco Pessoa, PhD, Wen Liu, PhD
 
Vol 11, No 4 (2015): July/August Opioid prescriptions before and after high-energy trauma Abstract
Stine T. Zwisler, MD, PhD, Jesper Hallas, MD, PhD, Morten S. Larsen, MD, Gitte Handberg, MD, Soeren Mikkelsen, MD, Thomas P. Enggaard, MD, PhD
 
Vol 13, No 4 (2017): July/August Opioid receptor antagonists in the treatment of pathological gambling Abstract
Maurizio Coppola, MD, Raffaella Mondola, MD
 
Vol 11, No 3 (2015): May/June Opioid regimens in patients with chronic pain with multiple cytochrome P450 defects Abstract
Forest Tennant, MD, DrPH
 
Vol 1, No 2 (2005): May/June Opioid Research: Methods and Protocols. Abstract   PDF
Mellar P. Davis, MD, FCCP
 
Vol 4, No 4 (2008): July/August Opioid rotation in patients with cancer: A review of the current literature Abstract
Athina Vadalouca, MD, PhD, FIPP, Eleni Moka, MD, Erifilli Argyra, MD, PhD, Panayiota Sikioti, MD, Ioanna Siafaka, MD, PhD
 
Vol 11, No 5 (2015): September/October Opioid rotation: A case example using methadone in spinal cord injury Abstract
Jayne Pawasauskas, PharmD, BCPS
 
Vol 2, No 4 (2006): July/August Opioid safety Abstract   PDF
Robert E. Enck, MD
 
Vol 7, No 4 (2011): July/August Opioid therapy for chronic pain: Physicians’ attitude and current practice patterns Abstract
Lucy Chen, MD, Mary Houghton, BA, Lindsey Seefeld, BS, Charlene Malarick, BSN, RN, Jianren Mao, MD, PhD
 
Vol 9, No 5 (2013): September/October Opioid therapy in children and adolescents: A physician's guide to risk assessment, monitoring, and mitigation of abuse Abstract
Jessica Anne George, MD, Sabine Kost-Byerly, MD, Constance L. Monitto, MD
 
Vol 10, No 1 (2014): January/February Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: A pilot assessment of the CoDem protocol Abstract
Boaz Gedaliahu Samolsky Dekel, MD, PhD, MA, Marco Tomasi, MD, Alessio Vasarri, MD, Alberto Gori, MD, Marco Adversi, MD, Anna Castagnoli, MD, GianFranco Di Nino, MD, Rita Maria Melotti, MD
 
Vol 13, No 5 (2017): September/October Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System Abstract
Marc R. Larochelle, MD, MPH, Noelle M. Cocoros, DSc, MPH, Jennifer Popovic, DVM, MA, Elizabeth C. Dee, MPH, Cynthia Kornegay, PhD, Jing Ju, PharmD, PhD, Judith A. Racoosin, MD, MPH
 
Vol 11, No 2 (2015): March/April Opioid treatment of experimental pain activates nuclear factor-κB Abstract
Peggy Compton, RN, PhD, Charles Griffis, CRNA, PhD, Elizabeth Crabb Breen, PhD, Matthew Torrington, MD, Ryan Sadakane, BS, Eshetu Tefera, MS, Michael R. Irwin, MD
 
Vol 17, No 4 (2021): July/August Opioid use disorder among hospitalized adults in North Carolina: Comparative analysis of national and statewide trends Abstract
Brook T. Alemu, PhD, MPH, Emily A. McCague, MPH, Nicole Holt, DrPH, Patrick A. Baron, PhD, MSPH, Olaniyi Olayinka, MD, MPH, Brian C. Martin, PhD, MBA
 
Vol 14, No 3 (2018): May/June Opioid use disorder and homelessness in the Veterans Health Administration: The challenge of multimorbidity Abstract
Theddeus Iheanacho, MD, Elina Stefanovics, PhD, Robert Rosenheck, MD
 
Vol 17, No 5 (2021): September/October Opioid use disorders national registries and opioids sales registries: A 10-year prevalence study from a middle-income country Abstract
Daniela Yucumá, MD, Ana Beatriz Pizarro, RN, Diego Alberto Moreno, MD, Juan David Mosos, MD, Marian Rincón-Montaña, MD, Diego Rosselli, MD
 
Vol 12, No 2 (2016): March/April Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients Abstract
Christopher Sankey, MD, CCFP (EM), Beatrice Setnik, PhD, Zoltan Harsanyi, BSc (Hon), MLS, MBA, PStat. (SSC), PSTAT® (ASA), Ken Michalko, PharmD, MBA, Zejiang Yang, PhD, Pierre Geoffroy, MDCM, MSc, FCFP, DABAM
 
Vol 14, No 3 (2018): May/June Opioid use in the acute setting: A survey of providers at an academic medical center Abstract
Douglas R. Oyler, PharmD, Kristy S. Deep, MD, Phillip K. Chang, MD
 
Vol 6, No 2 (2010): March/April Opioid use in young veterans Abstract
Phipson C. Wu, PharmD, BCPS, Courtney Lang, PharmD, BCPS, Noelle K. Hasson, PharmD, Steven H. Linder, MD, David J. Clark, MD
 
Vol 14, No 4 (2018): July/August Opioid use: Case-control analyses of worker's compensation data Abstract
Ulrike Ott, PhD, MSPH, Matthew S. Thiese, PhD, MSPH, Brenden B. Ronna, BS, Kristine Hegmann, MSPH, CIC, Kurt T. Hegmann, MD, MSPH
 
Vol 15, No 1 (2019): January/February Opioid utilization patterns among patients with cancer and non-cancer pain Abstract
Catherine J. Datto, MD, MS, Yiqun Hu, MD, PhD, Eric Wittbrodt, PharmD, MPH, Perry G. Fine, MD
 
Vol 8, No 1 (2012): January/February Opioid withdrawal-induced hypomania: A case series Abstract
Navid Khalili, MD, Shahrokh Sardarpour Gudarzi, MD
 
Vol 7, No 6 (2011): November/December Opioid-dependent error processing Abstract
James Fellows-Smith, MBBS, MMedSc, MRCPsych, FRANZCP, FAchAM
 
Vol 5, No 3 (2009): May/June Opioid-induced bowel dysfunction in cancer-related pain: Causes, consequences, and a novel approach for its management Abstract
Peter Holzer, PhD, Sam H. Ahmedzai, BSc, MBChB, FRCP, Norbert Niederle, MD, Petra Leyendecker, PhD, Michael Hopp, MD, Björn Bosse, Statistics (Diploma), Ingrid Spohr, PhD, Karen Reimer, MD
 
Vol 15, No 1 (2019): January/February Opioid-induced constipation in chronic pain: Experience with 180 patients Abstract
Ignacio Velázquez Rivera, MD, Lourdes Velázquez Clavarana, BSc, Pilar García Velasco, BSc, Carmen Melero Ramos, BSc
 
Vol 15, No 5 (2019): September/October Opioid-induced constipation in mixed chronic pain patients: Prevalence and predictors analysis Abstract
Boaz Gedaliahu Samolsky Dekel, MD, PhD, Maria Cristina Sorella, MD, Alessio Vasarri, MD, Alberto Gori, MD, Rita Maria Melotti, MD
 
Vol 5, No 3 (2009): May/June Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: Findings from the National Health and Wellness Survey Abstract
Timothy Bell, MHA, Kathy Annunziata, MA, John B. Leslie, MD, MBA
 
Vol 4, No 3 (2008): May/June Opioid-induced hyperalgesia: Pathophysiology and clinical implications Abstract
Sukanya Mitra, MD, MAMS
 
Vol 16, No 5 (2020): September/October Opioid-related harm in a quaternary pediatric hospital: A 5-year review Abstract
David Greaney, MB BCh, BAO, FRCA, MSc, FJFICMI, Renu Roy, BSP, MSc, RPh, Conor McDonnell, MD, MB BCh, BAO, FFARCSI
 
Vol 17, No 3 (2021): May/June Opioid-related hospitalizations and intravenous drug users: Sociodemographic, spatial, and comorbid associations among hospital inpatients and community-based harm reduction organization participants Abstract
Jacklynn De Leon, BS, MPH, Sheniz Moonie, PhD, Jay J. Shen, PhD, Karen S. Gutierrez, BS, Chad L. Cross, PhD, PStat®
 
Vol 2, No 3 (2006): May/June Opioids and brain imaging Abstract   PDF
Shyam Balasubramanian, MBBS, MD, FRCA, Patricia Morley-Forster, MD, FRCPC, Yves Bureau, PhD
 
Vol 2, No 2 (2006): March/April Opioids and Down’s syndrome Abstract   PDF
Federica Mafrica, MD, Vincenzo Fodale, MD
 
Vol 13, No 1 (2017): January/February Opioids and nonopioids for postoperative pain control in patients with chronic kidney disease Abstract
Michele Binhas, MD, Julia Egbeola-Martial, MD, Michael D. Kluger MD, MPH, Francoise Roudot-Thoraval, MD, Philippe Grimbert MD, PhD
 
Vol 3, No 3 (2007): May/June Opioids applied topically to painful cutaneous malignant ulcers in a palliative care setting Abstract   PDF
Giovambattista Zeppetella, FRCP, Giampiero Porzio, MD, Federica Aielli, MD
 
Vol 12, No 1 (2016): January/February Opioids for outpatients with cancer in their last year of life: A nationwide pharmacoepidemiological study Abstract
Siri Brelin, MD, Olav M. Fredheim, MD, PhD, Jon H. Loge, MD, PhD, Svetlana Skurtveit, PhD, Tom B. Johannesen, MD, PhD, Nina Aass, MD, PhD, Stig Ottesen, MD, PhD, Marianne J. Hjermstad, PhD
 
Vol 2, No 1 (2006): January/February Opioids in the parturient with chronic nonmalignant pain: A retrospective review Abstract   PDF
Ibrahim Hadi, MD, FRCPC, Orlando da Silva, MD, FRCPC, Renato Natale, MD, FRCSC, David Boyd, MD, FRCPC, Patricia K. Morley-Forster, MD, FRCPC
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Opioids with abuse-deterrent properties: A regulatory and technological overview Abstract
J. David Haddox, DDS, MD
 
Vol 1, No 4 (2005): September/October Opioids: The role in headache pharmacotherapy Abstract   PDF
Rob Hutchison, PharmD
 
Vol 3, No 3 (2007): May/June Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: A randomized, double-blind, prospective pilot study Abstract   PDF
Scott Hamann, PhD, MD, Paul Sloan, MD
 
Vol 1, No 1 (2005): March/April Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics Abstract   PDF
Kyriaki Mystakidou, MD, PhD, Emmanuela Katsouda, MD, Efi Parpa, BA, MA, Marinos L. Tsiatas, MD, PhD, Lambros Vlahos, MD, PhD
 
Vol 6, No 3 (2010): May/June Outcome of acute heroin overdose requiring intensive care unit admission Abstract
Leonidas Grigorakos, MD, PhD, Katerina Sakagianni, MD, Evdoxia Tsigou, MD, George Apostolakos, MD, Giannis Nikolopoulos, MD, Dimitris Veldekis, MD
 
Vol 5, No 2 (2009): March/April Out-of-hospital opioid therapy of palliative care patients with “acute dyspnoea”: A retrospective multicenter investigation Abstract
Christoph H. R. Wiese, MD, Utz E. Bartels, MD, Bernhard M. Graf, MD, Gerd G. Hanekop, MD
 
Vol 5, No 4 (2009): July/August Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice Abstract
Michelle McKenzie, MPH, Amy Nunn, MS, ScD, Nickolas D. Zaller, PhD, Alexander R. Bazazi, BA, Josiah D. Rich, MD, MPH
 
Vol 14, No 2 (2018): March/April Oxycodone is safe and effective for general anesthesia Abstract
Stefan Wirz, PhD, MD, Richard K. Ellerkmann, PhD, MD, Martin Soehle, PhD, MD, Christian-Dieter Wirtz, MD
 
Vol 12, No 1 (2016): January/February Oxycodone with an opioid receptor antagonist: A review Abstract
Mellar P. Davis, MD, FCCP, FAAHPM, Harold W. Goforth, MD
 
Vol 6, No 1 (2010): January/February Oxycodone/acetaminophen at low dosage: An alternative pain treatment for patients with rheumatoid arthritis Abstract
William Raffaeli, MD, Claudia Pari, MD, Angelo Corvetta, MD, Donatella Sarti, PhD, Valentina Di Sabatino, MD, Giovanni Biasi, MD, Maurizio Galeazzi, MD
 
Vol 14, No 1 (2018): January/February Oxycodone/naloxone in postoperative pain management of surgical patients Abstract
Ioannis D. Gkegkes, MD, PhD, Evelyn Eleni Minis, MD, Christos Iavazzo, MD, MSc, PhD
 
Vol 13, No 3 (2017): May/June Oxycodone-induced neurotoxicity secondary, to concurrent voriconazole use in a patient with cancer Abstract
Lana Alghothani, MD, Jillian Gustin, MD
 
Vol 7, No 3 (2011): May/June Oxycodone-related side effects: Impact on degree of bother, adherence, pain relief, satisfaction, and quality of life Abstract
Kathryn P. Anastassopoulos, MS, Wing Chow, MPH, PharmD, Stacey J. Ackerman, MSE, PhD, Crisanta Tapia, MHS, Carmela Benson, MS, Myoung S. Kim, MBA, MA, PhD
 
Vol 4, No 2 (2008): March/April OxyContin® use and misuse in three populations: Substance abuse patients, pain patients, and criminal justice participants Abstract
Martha J. Wunsch, MD, Karen L. Cropsey, PsyD, Eleanor D. Campbell, MS, Janet S. Knisely, PhD
 
Vol 4, No 3 (2008): May/June Oxymorphone and oxymorphone extended release: A pharmacotherapeutic review Abstract
Paul Alexander Sloan, MD, Robert L. Barkin, PharmD, MBA
 
Vol 2, No 3 (2006): May/June Pain control for dying patients: Hastening death or ensuring comfort? Abstract   PDF
Marshall B. Kapp, JD, MPH
 
Vol 11, No 6 (2015): November/December Pain intensity and interference with functioning and well-being in subgroups of patients with chronic pain treated with once-daily hydrocodone tablets Abstract
Adrian Bartoli, MD, Edward Michna, MD, Ellie He, PhD, Warren Wen, PhD
 
Vol 4, No 6 (2008): November/December Pain management in chronic kidney disease: The pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients Abstract
Sara N. Davison, MD, MHSc (bioethics), FRCP(C), Patrick R. Mayo, PhD, SFO
 
Vol 8, No 3 (2012): May/June Pain management with tapentadol: a better and safer alternative to oxycodone Abstract
Shailendra Kapoor, MD
 
Vol 6, No 2 (2010): March/April PAIN MEDICATION PRESCRIPTION AND BORDERLINE PERSONALITY DISORDER: A PILOT STUDY Abstract
Randy A. Sansone, MD, Michelle Mueller, MD, Amy Mercer, MD, Michael W. Wiederman, MD
 
Vol 1, No 1 (2005): March/April Pain Medicine and Management: Just the Facts Abstract   PDF
Gilbert J. Fanciullo, MD, MS
 
Vol 7, No 5 (2011): September/October Pain responsiveness to opioids: Central versus peripheral neuropathic pain Abstract
Howard S. Smith, MD, Patrick D. Meek, PharmD, MSPH
 
Vol 8, No 1 (2012): January/February Palliative care in the management of lung cancer: Analgesic utilization and barriers to optimal pain management Abstract
Charles B. Simone II, MD, Neha Vapiwala, MD, Margaret K. Hampshire, BSN, James M. Metz, MD
 
Vol 10, No 3 (2014): May/June Patient aberrant drug taking behaviors in a large family medicine residency program: A retrospective chart review of screening practices, incidence, and predictors Abstract
Matthew Lewis, PharmD, Christopher M. Herndon, PharmD, BCPS, CPE, John T. Chibnall, PhD
 
Vol 16, No 3 (2020): May/June Patient and pediatric caregiver experiences and expectations about opioid risk education and counselling Abstract
Tanvee Thakur, BPharm, MS, Betty Chewning, PhD
 
Vol 15, No 4 (2019): July/August Patient health literacy and the receipt of opioids in the emergency department Abstract
Joseph A. Dayaa, MS, Montika Bush, PhD, MS, Natalie L. Richmond, BA, Lewis S. Nelson, MD, Timothy F. Platts-Mills, MD, MSc
 
Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" Patient satisfaction with clinic-based medication pick up: Addressing pharmacy-level challenges to buprenorphine access Abstract
Elizabeth Kolb, MS, Mark Rueth, PharmD
 
Vol 6, No 5 (2010): September/October Patient selection and trialing techniques utilizing low-dose intrathecal morphine for chronic nonmalignant pain: A report of two cases Abstract
Jay S. Grider, DO, PhD, Michael E. Harned, MD, Paul A. Sloan, MD
 
Vol 12, No 5 (2016): September/October Patient-relevant outcomes and health-related quality of life in patients with chronic, severe, noncancer pain treated with tapentadol prolonged release—Using criteria of health technology assessment Abstract
Johannes FX Hofmann, PhD, Arun Lal, MSc, MBA, Maike Steffens, Robert Boettger
 
Vol 4, No 1 (2008): January/February Patients with chronic pain on opioid therapy taking dronabinol: Incidence of false negatives using radioimmunoassay Abstract
Sanjeet Narang, MD, Ajay D. Wasan, MD, MSc, Edgar L. Ross, MD, Edward Michna, MD, Jui-Yuan Chen, MD, Robert N. Jamison, PhD
 
Vol 15, No 6 (2019): November/December Patterns in opioid prescription in the United States by region and prescribers over a 4-year period Abstract
Luisa M. Bigal, BA, Kristen Bibeau, PhD, Stephanie Dumbar, PhD
 
Vol 9, No 5 (2013): September/October Patterns of care and side effects for patients prescribed methadone for treatment of chronic pain Abstract
Tara A. Macey, PhD, Melissa B. Weimer, DO, MCR, Elizabeth M. Grimaldi, BA, Steven K. Dobscha, MD, Benjamin J. Morasco, PhD
 
Vol 16, No 1 (2020): January/February Patterns of heroin use following index prescription opioid exposure Abstract
Scott M. Sexton, PharmD, Christopher M. Herndon, PharmD, BCACP, Jordan D. Sinclair, PharmD
 
Vol 3, No 1 (2007): January/February Patterns of illicit drug use and retention in a methadone program: A longitudinal study Abstract   PDF
Ingrid Davstad, MA, Marlene Stenbacka, PhD, Anders Leifman, MSE, Olof Beck, PhD, Seher Korkmaz, MD, PhD, Anders Romelsjo, MD, PhD
 
Vol 8, No 1 (2012): January/February PCA-derived factors that may be predictive of postoperative pain in pediatric patients: A possible role for the PCA ratio Abstract
Conor Mc Donnell, MD, MB, Carolyne Pehora, MN, Mark W. Crawford, MBBS
 
Vol 16, No 1 (2020): January/February Perceived patient benefits from using prescription opioids and other therapies to manage persistent pain Abstract
Farzana Mitra, MD, MBBS, FRACGP, DA, Dip. AC, Torres Woolley, PhD, MPHTM
 
Vol 15, No 2 (2019): March/April Perceptions of opioid misuse and chronic pain: A qualitative assessment of Rhode Island commercial fishing captains Abstract
Travis Brown, BS, Paul George, MD, MHPE
 
Vol 10, No 1 (2014): January/February Perioperative dilemma: Challenges of the management of a patient on mega doses of morphine and methadone Abstract
Alan David Kaye, MD, PhD, DABA, DABPM, DABIPP, Aymen A. Alian, MD, Nalini Vadivelu, MD, Keun Sam Chung, MD
 
Vol 17, No 3 (2021): May/June Perioperative gabapentinoid use lowers short-term opioid consumption following lower limb arthroplasty: Systematic review and meta-analysis Abstract
Ryan Campbell, MD, Jacqueline Nguyen Khuong, MD, Zhengyang Liu, BBiomed, Carla Borg, MD, Sarah Jackson, BBiomed, Dhruvesh M. Ramson, MBBS (Hons), Juliana Kok, MD, Ned Douglas, MD, Jahan C. Penny-Dimri, MBBS (Hons), Luke A. Perry, MBBS (Hons)
 
Vol 2, No 6 (2006): November/December Perioperative management of opioid-tolerant chronic pain patients Abstract   PDF
Dima Rozen, MD, Noah P. DeGaetano, MD
 
Vol 16, No 6 (2020): November/December Perioperative methadone prescribing and association with respiratory depression Abstract
Sarah E. Bova, PharmD, Rachel M. Kruer, PharmD, Suzanne A. Nesbit, PharmD, Michael C. Grant, MD, Andrew S. Jarrell, PharmD
 
Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" Perioperative outcomes for patients on chronic buprenorphine undergoing spine surgery: A case series Abstract
Ashley L. Sharp, MD, Stephanie Gilbert, MD, Danielle N. Perez, MD, Kerstin Kolodzie, MD, PhD, MAS, Matthias Behrends, MD
 
Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" Perioperative pain management and outcomes in patients who discontinued or continued pre-existing buprenorphine therapy Abstract
Aamer Attaar, PharmD, BCPS, Molly Curran, PharmD, BCPS, BCCCP, Lyndsi Meyenburg, PharmD, BCPS, Richard Bottner, DHA, PA-C, Clarissa Johnston, MD, Kirsten Roberts Mason, PharmD, BCPS
 
Vol 10, No 6 (2014): November/December Perioperative substance use disorder, opioid diversion, and opioid misuse by a medical professional undergoing orthopedic surgery Abstract
Dermot Maher, MD, MS, Michael Kissen, MD, Itai Danovitch, MD, MBA, Roya Yumul, MD, PhD, Charles Louy, PhD, MD
 
Vol 7, No 1 (2011): January/February Peripheral opioid receptor agonists for analgesia: A comprehensive review Abstract
Nalini Vadivelu, MD, Sukanya Mitra, MD, Roberta L. Hines, MD
 
Vol 3, No 4 (2007): July/August Personality traits and sensitivity to pain in male chronic opioid addicts Abstract
Elon Eisenberg, MD, Doron Cohen, MA, Eli Lawental, PhD, Dorit Pud, PhD
 
Vol 3, No 6 (2007): November/December Pharmacist-physician collaboration in pain management practice Abstract
Jennifer M. Strickland, PharmD, BCPS, Angela Huskey, PharmD, David B. Brushwood, RPh, JD
 
Vol 11, No 4 (2015): July/August Pharmacoepidemiology of opiate use in the neonatal ICU: Increasing cumulative doses and iatrogenic opiate withdrawal Abstract
Tamorah Lewis, MD, Betty Luan Erfe, BS, Tarrah Ezell, BS, Estelle Gauda, MD
 
Vol 9, No 4 (2013): July/August Pharmacokinetic evaluation of tapentadol extended-release tablets in healthy subjects Abstract
Peter N. Zannikos, PhD, Johan W. Smit, PhD, Hans-Jürgen Stahlberg, MD, Birger Wenge, PhD, Vera M. Hillewaert, MSc, Mila S. Etropolski, MD
 
Vol 6, No 1 (2010): January/February Pharmacokinetics of intranasal fentanyl spray in patients with cancer and breakthrough pain Abstract
Stein Kaasa, MD, PhD, Kristin Moksnes, MD, Thomas Nolte, MD, Daniele Lefebvre-Kuntz, MD, Lars Popper, MS, PhD, Hans Georg Kress, MD, PhD
 
Vol 4, No 2 (2008): March/April Pharmacokinetics of oral tramadol in patients with liver cancer Abstract
Hassan Ibraheem Mohamed Kotb, MD, Ihab Ahmed Fouad, PhD, Khaled Mohamed Fares, MD, Mostafa Galal Mostafa, MD, Ahmad M. Abd El-Rahman, MSc
 
Vol 10, No 5 (2014): September/October Pharmacological and toxicological profile of opioid-treated, chronic low back pain patients entering a mindfulness intervention randomized controlled trial Abstract
Aleksandra Zgierska, MD, PhD, Margaret L. Wallace, PharmD, BCACP, Cindy A. Burzinski, MS, Jennifer Cox, BS, Miroslav Backonja, MD
 
Vol 5, No 2 (2009): March/April Pharmacological management of cancer pain Abstract
Marcos L. Montagnini, MD, FACP, Carolyn R. Zaleon, PharmD
 
Vol 16, No 5 (2020): September/October Pharmacy multidisciplinary stewardship program for high-risk patients prescribed opioids in an academic clinic Abstract
Yvette Hellier, PharmD, Machelle Wilson, PhD, Angela Leahy, PharmD, Kevin Burnham, MD
 
Vol 14, No 5 (2018): September/October Pharmacy-related theft of controlled substances: RxPATROL® findings Abstract
Jennifer G. Erensen, MPH, J. David Haddox, DDS, MD, Maigh S. Attre, Luis N. Bauza, MS, CPP
 
Vol 10, No 4 (2014): July/August Photos from International Conference on Opioids, June 8-10, 2014 Abstract
JOM Editors
 
Vol 12, No 4 (2016): July/August Physician conviction for prescription related deaths: How will this affect the opioid debate? Abstract
Humair Rana, MD, Brian Braithwaite, MD
 
Vol 8, No 1 (2012): January/February Physician identification of opioid diversion: A difficult diagnosis Abstract
Gary M. Reisfield, MD, Paul A. Sloan, MD
 
Vol 9, No 6 (2013): November/December Physician management of moderate-to-severe acute pain: Results from the Physicians Partnering Against Pain (P3) Study Abstract
Bill H. McCarberg, MD, Aarti A. Patel, PharmD, MBA, Carmela J. Benson, MS, Samir H. Mody, PharmD, MBA, Wing Chow, PharmD, MPH, Carla L. Zema, PhD, Gary J. Vorsanger, PhD, MD, Myoung S. Kim, PhD, MBA, MA
 
Vol 8, No 2 (2012): March/April Physician survey examining the impact of an educational tool for responsible opioid prescribing Abstract
Aaron Young, PhD, Kelly C. Alfred, MS, Philip P. Davignon, MA, LaSharn M. Hughes, MBA, Lisa A. Robin, MLA, Humayun J. Chaudhry, DO
 
Vol 3, No 4 (2007): July/August Physician-related barriers to cancer pain management with opioid analgesics: A systematic review Abstract
Ramune Jacobsen, MS, MPH, Per Sjøgren, MD, DMS, Claus Møldrup, PhD, Lona Christrup, PhD
 
Vol 5, No 3 (2009): May/June Physicians’ pain management confidence versus competence Abstract
Mark A. Douglass, PharmD, Gail M. Sanchez, PharmD, BCPS, Daniel P. Alford, MD, MPH, Gail Wilkes, RNC, MS, AOCN, Jeffrey L. Greenwald, MD
 
Vol 7, No 6 (2011): November/December Plasma cyclic guanosine 3′,5′-monophosphate levels: A marker of glutamate-nitric oxide-guanyl cyclase activity? Abstract
Thomas Engelhardt, MD, PhD, FRCA, Christian Zaarour, MD, Mark W. Crawford, MBBS, FRCPC
 
Vol 16, No 4 (2020): July/August Polysubstance abuse associated with more frequent opioid use among patients in rural primary care settings Abstract
David L. Albright, PhD, Justin McDaniel, PhD, Kirsten Laha-Walsh, MSW, Beth Morrison, MS, Shanna McIntosh, MS
 
Vol 2, No 1 (2006): January/February Poor pain relief and possible toxicity from high-dose intrathecal opioid treatment: Report of two cases Abstract   PDF
Anca Popescu, MD, Rajorshi Mitra, MD, Jane Ballantyne, MD, FRCA
 
Vol 7, No 3 (2011): May/June Positive and negative subjective effects of extended-release oxymorphone versus controlled-release oxycodone in recreational opioid users Abstract
Kerri A. Schoedel, PhD, Stephen McMorn, PhD, Bijan Chakraborty, MStat, Susan L. Potts, MS, Kathleen Zerbe, RN, Edward M. Sellers, MD, PhD
 
Vol 11, No 3 (2015): May/June Positive subjective measures in abuse liability studies and real-world nonmedical use: Potential impact of abuse-deterrent opioids on rates of nonmedical use and associated healthcare costs Abstract
Alan G. White, PhD, Joseph LeCates, PhD, Howard G. Birnbaum, PhD, Wendy Cheng, MPH, MPhil, Carl L. Roland, PharmD, MS, Jack Mardekian, PhD
 
Vol 15, No 2 (2019): March/April Postlaparotomy pain management: Comparison of patient-controlled analgesia pump alone, with subcutaneous bupivacaine infusion, or with injection of liposomal bupivacaine suspension Abstract
Harish M. Yalmanchili, MD, Stephanie N. Buchanan, MD, Lowell W. Chambers, MD, FACS, Jantzen D. Thorns, MD, Nicholas A. McKenzie, MD, Alisha D. Reiss, MD, Maurice P. Page, MD, Victor V. Dizon, DO, FACOS, Sheila E. Brooks, RN, BSN, Lynn E. Shaffer, PhD, Scott T. Lovald, PhD, Thomas H. Hartranft, MD, FACS, Phillip D. Price, MD, FACS
 
Vol 5, No 6 (2009): November/December Postoperative analgesia after radical prostatectomy with high-dose intrathecal morphine and intravenous naloxone: A retrospective review Abstract
Annette Rebel, MD, Paul Sloan, MD, Michael Andrykowski, PhD
 
Vol 13, No 4 (2017): July/August Postoperative pain scores and opioid consumption in opioid-dependent patients with cancer after intraoperative remifentanil analgesia: A prospective case-controlled study Abstract
Cyrus Motamed, MD, Juliette Audibert, MD, Aline Albi-Feldzer, MD, Gaelle Bouroche, MD, Christian Jayr, MD, PhD
 
Vol 15, No 4 (2019): July/August Postoperative surgical trainee opioid prescribing practices (POST-OPP): A national survey Abstract
David J. Hall, MD, Juan C. Mira, MD, Melissa R. Hoffman, MD, ND, Hari B. Keshava, MD, MS, Kevin R. Olsen, MD, John C. Hardaway, MD, PhD, Patrick W. Underwood, MD, Kristy L. Hawley, MD, MPH, Patricia L. Turner, MD, Ajay B. Antony, MD, Terrie Vasilopoulos, PhD, Nicolas J. Mouawad, MD, MPH, MBA
 
Vol 8, No 4 (2012): July/August Postsurgical patient-controlled opioid self-administration is greater in hospitalized abstinent smokers than nonsmokers Abstract
Caren L. Steinmiller, PhD, Christina Diederichs, BS, Timothy A. Roehrs, PhD, Maren Hyde-Nolan, MS, Thomas Roth, PhD, Mark K. Greenwald, PhD
 
Vol 7, No 5 (2011): September/October Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency Abstract
Eugenia Oviedo-Joekes, PhD, David C. Marsh, MD, Daphne Guh, MSc, Suzanne Brissette, MD, Martin T. Schechter, MD, PhD
 
Vol 10, No 1 (2014): January/February Potential impact of abrupt opioid therapy discontinuation in the management of chronic pain: A pilot study on patient perspective Abstract
Joy Hao, MD, PhD, David Lucido, PhD, Ricardo A. Cruciani, MD, PhD
 
Vol 17, No 4 (2021): July/August Potential innovative targets in the treatment of pain: Combined μ and NOP receptor agonists Abstract
Raphael J. Leo, MA, MD
 
Vol 16, No 3 (2020): May/June Potential pharmacological perspectives for the treatment/prevention of the SARS-COV-2 infection in opioid dependent patients Abstract
Maurizio Coppola, MD, Raffaella Mondola, MD
 
Vol 4, No 5 (2008): September/October Prediction of withdrawal symptoms during opioid detoxification Abstract
Boukje A. G. Dijkstra, MSc, Paul F. M. Krabbe, PhD, Cor A. J. De Jong, MD, PhD, Cees P. F. van der Staak, PhD
 
Vol 15, No 3 (2019): May/June Pre-existing opioid use disorder and postoperative outcomes after appendectomy or cholecystectomy: A multi-state analysis, 2007-2014 Abstract
Alina Boltunova, MD, Robert S. White, MD, MS, Selaiman Noori, MD, Stephanie A. Chen, BA, Licia K. Gaber-Baylis, BA, Roniel Weinberg, MD
 
Vol 9, No 1 (2013): January/February Preliminary data on a new opioid risk assessment measure: The Brief Risk Interview Abstract
Ted Jones, PhD, Todd Moore, PhD
 
Vol 8, No 4 (2012): July/August Prepping, another cause for diversion of opioids Abstract
Frank A. Kunkel, MD, Isabel Ahrendt
 
Vol 14, No 5 (2018): September/October Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study Abstract
Julianna Fernandez, PharmD, BCPS, CGP, James Douglas Thornton, PhD, PharmD, BCPS, Sanika Rege, MS, Benjamin Lewing, MS, Shweta Bapat, BPharm, Qingqing Xu, MS, Marc L. Fleming, PhD, MPH, RPH
 
Vol 3, No 6 (2007): November/December Prescribing opioids in renal failure Abstract
Joanne Droney, MB, BCh, MRCP(I), Jeremy Levy, PhD, FRCP, Columba Quigley, FRCP
 
Vol 5, No 4 (2009): July/August Prescription drug fatalities among women in rural Virginia: A study of medical examiner cases Abstract
Martha J. Wunsch, MD, Kent Nakamoto, PhD, Paul A. Nuzzo, MA, George Behonick, PhD, William Massello, MD, Sharon L. Walsh, PhD
 
Vol 2, No 5 (2006): September/October Prescription opioid abuse among drug-involved street-based sex workers Abstract   PDF
Hilary L. Surratt, PhD, James A. Inciardi, PhD, Steven P.q Kurtz, PhD
 
Vol 1, No 2 (2005): May/June Prescription opioid dependence and treatment with methadone in pregnancy Abstract   PDF
Stephanie C. Eken Sander, MD, Lon R. Hays, MD, MBA
 
Vol 15, No 4 (2019): July/August Prescription Opioid Misuse Index in sickle cell patients: A brief questionnaire to assess at-risk for opioid abuse Abstract
Wally R. Smith, MD, Donna K. McClish, PhD, John D. Roberts, MD, Osama Kandalaft, MD, Bassam Dahman, PhD, Janet Knisely, PhD, James Levenson, MD, Susan Roseff, MD, Imo P. Aisiku, MD
 
Vol 16, No 6 (2020): November/December Prescription opioid use duration and beliefs about pain and pain medication in primary care patients Abstract
Philip Day, PhD, Scott Secrest, MPH, Dawn Davis, MD, Joanne Salas, MPH, Carissa van den Berk-Clark, PhD, MSW, Neelima Kale, PhD, MD, MBA, Catherine Hearing, MPH, F. David Schneider, MD, MSPH, Jeffrey F. Scherrer, PhD, ARCHNet Investigators
 
Vol 17, No 3 (2021): May/June Prescription opioid use during pregnancy and risk for preterm birth or term low birthweight Abstract
Julia D. Interrante, MPH, Stacey L. P. Scroggs, PhD, Carol J. Hogue, PhD, Jan M. Friedman, MD, Jennita Reefhuis, PhD, Michael W. Jann, PharmD, Cheryl S. Broussard, PhD, National Birth Defects Prevention Study
 
Vol 4, No 2 (2008): March/April Prescription opioid use in the rural Appalachia: A community-based study Abstract
Jennifer R. Havens, PhD, MPH, Robert Walker, MSW, LCSW, Carl G. Leukefeld, DSW
 
Vol 16, No 5 (2020): September/October Prescriptions for opioids and opioid-included polypharmacy: An analysis of the National Hospital Ambulatory Medical Care Survey Abstract
Jessica C. Rivera, MD, PhD
 
Vol 17, No 1 (2021): January/February Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location Abstract
Lynn R. Kohan, MD, Dalia Elmofty, MD, Israel Pena, MD, Chuanhong Liao, MS
 
Vol 3, No 2 (2007): March/April Prevalence and characteristics of breakthrough pain in patients receiving opioids for chronic back pain in pain specialty clinics Abstract   PDF
Daniel S. Bennett, MD, Steven Simon, MD, RPh, Michael Brennan, MD, Steven A. Shoemaker, MD
 
Vol 12, No 4 (2016): July/August Prevalence and correlates of coprescribing anxiolytic medications with extensive prescription opioid use in Veterans Health Administration patients with metastatic cancer Abstract
Declan T. Barry, PhD, Mehmet Sofuoglu, MD, Robert D. Kerns, PhD, Ilse R. Wiechers, MD, Robert A. Rosenheck, MD
 
Vol 9, No 3 (2013): May/June Prevalence and cost of diagnosed opioid abuse in a privately insured population in the United States Abstract
Carl L. Roland, PharmD, Ashish V. Joshi, PhD, Jack Mardekian, PhD, Steven C. Walden, PharmD, MBA, James Harnett, PharmD, MS
 
Vol 3, No 3 (2007): May/June Prevalence of opioid dependence in spine surgery patients and correlation with length of stay Abstract   PDF
Mohammad Sami Walid, MD, PhD, Leon Hyer, PhD, Mohammed Ajjan, MD, Aaron C. M. Barth, Joe Sam Robinson, Jr, MD
 
Vol 4, No 4 (2008): July/August Prevalence of opioid dispensings and concurrent gastrointestinal medications in an elderly population from Ontario, Canada Abstract
Rachel Williams, PhD, MS, Nevzeta Bosnic, BA, Ashlee W. Duncan, PhD, MS, Michael Brogan, BA, Suzanne F. Cook, PhD
 
Vol 10, No 2 (2014): March/April Preventing and managing aberrant drug-related behavior in primary care: Systematic review of outcomes evidence Abstract
Charles E. Argoff, MD, Meldon Kahan, MD, Edward M. Sellers, MD
 
Vol 7, No 2 (2011): March/April Primary care physician opinion survey on FDA Opioid Risk Evaluation and Mitigation Strategies Abstract
Kieran A. Slevin, MD, Michael A. Ashburn, MD, MPH
 
Vol 15, No 3 (2019): May/June Primary care physicians’ perspectives on Veterans who obtain prescription opioids from multiple healthcare systems Abstract
Felicia R. Bixler, MS, Thomas R. Radomski, MD, MS, Susan L. Zickmund, PhD, KatieLynn M. Roman, BA, Leslie R. M. Hausmann, PhD, Carolyn T. Thorpe, PhD, MPH, Jennifer A. Hale, BS, Florentina E. Sileanu, MS, Walid F. Gellad, MD, MPH
 
Vol 12, No 6 (2016): November/December Primary care providers’ prescribing practices of opioid controlled substances Abstract
Lisa B. E. Shields, MD, Soraya Nasraty, MD, MMM, CPE, Alisha D. Bell, MSN, RN, CPN, Anil N. Vinayakan, MD, Raghunath S. Gudibanda, MD, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, FAAP
 
Vol 7, No 6 (2011): November/December Primary care survey of the value and effectiveness of the Washington State Opioid Dosing Guideline Abstract
Josiah S. Morse, MPH, Hal Stockbridge, MD, MPH, Kathleen B. Egan, MPH, Jaymie Mai, PharmD, Thomas Wickizer, PhD, Gary M. Franklin, MD, MPH
 
Vol 2, No 1 (2006): January/February Problematic terminology for problematic drug use Abstract   PDF
David Cowan, MD, BSc (Hons), PhD
 
Vol 1, No 1 (2005): March/April Progress in pain management: Where are we? Abstract   PDF
Frederick J. Goldstein, PhD, FCP
 
Vol 13, No 5 (2017): September/October Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients Abstract
Mihran Ara Yenikomshian, MBA, Alan G. White, PhD, Michael E. Carson, BS, Louis P. Garrison, PhD, Gary M. Oderda, PharmD, MPH, Joseph E. Biskupiak, PhD, MBA, Patrick R. Hlavacek, MPH, Carl L. Roland, PharmD, MS
 
Vol 9, No 4 (2013): July/August Prolonged QT interval by methadone: Relevance for daily practice? A prospective study in patients with cancer and noncancer pain Abstract
Marieke H. J. van den Beuken-van Everdingen, MD, PhD, José W. Geurts, MSc, Jacob Patijn, MD, PhD
 
Vol 14, No 4 (2018): July/August Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified Abstract
Jessica J. Wyse, PhD, Benjamin J. Morasco, PhD, Steven K. Dobscha, MD, Michael I. Demidenko, BS, Thomas H. A. Meath, MPH, Travis I. Lovejoy, PhD, MPH
 
Vol 3, No 2 (2007): March/April Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients Abstract   PDF
Laxmaiah Manchikanti, MD, James Giordano, PhD, Mark V. Boswell, MD, PhD, Bert Fellows, MA, Rajeev Manchukonda, BDS, Vidyasagar Pampati, MSc
 
Vol 6, No 3 (2010): May/June Psychosocial distress in patients treated for cancer pain: A prospective observational study Abstract
Sean O’Mahony, MB BCh, BAO, Joseph Lucien Goulet, PhD, Richard Payne, MD
 
Vol 14, No 5 (2018): September/October Psychosocial interventions for chronic pain and comorbid prescription opioid use disorders: A narrative review of the literature Abstract
Valerie Hruschak, MSW, Gerald Cochran, PhD, Ajay D. Wasan, MD, MSc
 
Vol 1, No 2 (2005): May/June PUMP TAMPERING POSSIBLE BY PATIENTS IN OPIOID ADMINISTRATION Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 11, No 6 (2015): November/December Quantification of oxycodone and morphine analytes in urine: Assessment of adherence Abstract
Michael E. M. Larson, PhD, Richard L. Berg, MS, Joyce Flanagan, PhD
 
Vol 15, No 3 (2019): May/June Race and ethnicity: Not factors in the prescribing of hydrocodone- and codeine-containing products in two pediatric emergency departments Abstract
Chris A. Rees, MD, MPH, Melanie Brooke Bernhardt, PharmD, Elizabeth A. Camp, PhD, Jessica S. Lin, BA, Corrie E. Chumpitazi, MD, MS
 
Vol 11, No 2 (2015): March/April Randomized double-blind placebo trial of duloxetine in perioperative spine patients Abstract
Lee Hyer, PhD, ABPP, Ciera Scott, MS, NCC, Christine M. Mullen, MA, Laura C. McKenzie, BA, Joe Sam Robinson Jr, MD
 
Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: “A case series” Abstract
Gurpreet Singh, MBBS, Jaya Sri Konakanchi, MBBS, Brandon Betsch, Aastha Thapa, Roopa Sethi, MD
 
Vol 9, No 3 (2013): May/June Rationale and design of the Oxycodone Users Registry: A prospective, multicenter registry of patients with nonmalignant pain Abstract
Myoung Kim, PhD, Wing Chow, PharmD, MPH, Carmela Benson, MS
 
Vol 6, No 4 (2010): July/August Rationales behind the choice of administration form with fentanyl: Delphi survey among Danish general practitioners Abstract
Ramune Jacobsen, PhD, Claus Møldrup, PhD, Lona Christrup, PhD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Reality and responsibility revisited: Stakeholder accountability in the effort to develop safer opioids Abstract
Steven D. Passik, PhD, Howard A. Heit, MD, Michael DeGeorge, PharmD
 
Vol 2, No 3 (2006): May/June Reality and responsibility: A commentary on the treatment of pain and suffering in a drug-using society Abstract   PDF
Steven D. Passik, PhD, Howard Heit, MD, FACP, FASAM, Kenneth L. Kirsh, PhD
 
Vol 12, No 4 (2016): July/August Reducing the community-prescribed opioid load: A public health approach to the opioid epidemic Abstract
Julia Lew, MS1, BSc, Kieran Moore, MD, CCFP(EM), FCFP, MPH, DTM&H, FRCPC
 
Vol 17, No 2 (2021): March/April Reduction in Schedule II opioid prescribing by primary care providers, orthopedic and general surgeons, and pain management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force Abstract
Lisa B. E. Shields, MD, Timothy A. Johnson, BS, Michael W. Daniels, MS, Alisha Bell, MSN, RN, CPN, Diane M. Siemens, PharmD, James T. Jennings, MD, MBA, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, MBA, FAAP
 
Vol 17, No 4 (2021): July/August Reduction of opioid use using regional anesthetic blocks after inguinal hernia repair in a high risk, safety net population Abstract
Sayeeda Rab, BS, Sudeepti Vedula, BS, Aziz M. Merchant, MD, FACS
 
Vol 6, No 5 (2010): September/October Reference intervals: A novel approach to detect drug abuse in a pain patient population Abstract
Amadeo Pesce, PhD, DABCC, Cameron West, PhD, Robert West, MS, Bridgit Crews, PhD, Charles Mikel, PhD, Perla Almazan, CLS, MT (ASCP), Sergey Latyshev, MS, Murray Rosenthal, DO, FAPA, Paul Horn, PhD
 
Vol 11, No 5 (2015): September/October Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate Abstract
Charles Argoff, MD, Paul Arnstein, RN, PhD, FAAN, Steven Stanos, DO, Cynthia Y. Robinson, PhD, Bradley S. Galer, MD, Errol Gould, PhD, Arnold Gammaitoni, PharmD
 
Vol 4, No 1 (2008): January/February Relationship between fentanyl dosage and immune function in the postoperative period Abstract
Israel Z. Yardeni, MD, Benzion Beilin, MD, Eduard Mayburd, MD, Yifat Alcalay, MSc, Hanna Bessler, PhD
 
Vol 5, No 4 (2009): July/August Relationship between rate of infusion and reinforcing strength of oxycodone in humans Abstract
Sandra D. Comer, PhD, Judy B. Ashworth, MD, Maria A. Sullivan, MD, PhD, Suzanne K. Vosburg, PhD, Phillip A. Saccone, BS, Richard W. Foltin, PhD
 
Vol 2, No 4 (2006): July/August Relative abuse potential of opioid formulations in Canada: A structured field study Abstract   PDF
Edward M. Sellers, MD, PhD, FRCPC, Reinhard Schuller, MSc, Myroslava K. Romach, MD, G. L. A. Horbay, PhD
 
Vol 10, No 4 (2014): July/August Remifentanil target-controlled infusion: A safe rescue protocol for unexpected severe postoperative pain Abstract
Cyrus Motamed, MD, Grégoire Weil, MD, Frederic Deschamps, MD, Valérie Billard, MD
 
Vol 3, No 5 (2007): September/October Remifentanil versus remifentanil with paracervical block on plasma remifentanil concentrations and pulmonary function tests for transvaginal ultrasound-guided oocyte retrieval Abstract
Berrin Gunaydin, MD, PhD, I. Kivilcim Ozulgen, MD, Ertan Ozturk, MD, Zeki T. Tekgul, MD, Kadir Kaya, MD
 
Vol 2, No 4 (2006): July/August Renal effects of opioid exposure: Considerations for therapeutic use Abstract   PDF
Kalpna Gupta, PhD, Marc L. Weber, MD
 
Vol 8, No 1 (2012): January/February Report of an HIV clinic-based pain management program and utilization of health status and health service by HIV patients Abstract
Ahashta Johnson, MD, Kathleen DiGangi Condon, ANP-BC, MS, MA, Ann Celeste Mapas-Dimaya, MD, Judith Schrager, RN, PMHNP-BC, Robert Grossberg, MD, Rosalyn Gonzalez, BA, CASAC, Sean O’Mahony, MB, BCh, BAO, MS
 
Vol 9, No 2 (2013): March/April Reported side effects, bother, satisfaction, and adherence in patients taking hydrocodone for non-cancer pain Abstract
Kathryn P Anastassopoulos, MS, Wing Chow, PharmD, Crisanta I. Tapia, MHS, Rebecca Baik, BS, Bruce Moskowitz, MD, Myoung S. Kim, PhD
 
Vol 8, No 5 (2012): September/October Rethinking methadone for the management of chronic pain Details
Gary M. Reisfield, MD, Paul A. Sloan, MD
 
Vol 17, No 4 (2021): July/August Retrospective study of the effect of opioid prescribing guidelines on prescribing practices in pediatric orthopedic sports medicine patients having knee surgery: A single institution's experience Abstract
Jeffrey G. Stepan, MD, MSc, Christine Goodbody, MD, Kanupriya Kumar, MD, Kathryn DelPizzo, MD, Peter Fabricant, MD, MPH, Pamela Wendel, MD
 
Vol 10, No 4 (2014): July/August Review article. Buprenorphine in the workers' compensation setting Abstract
Stephen Colameco, MD, MEd, FASAM, Mel Pohl, MD, FASAM
 
Vol 10, No 4 (2014): July/August Review article. Opioid analgesics: Does potency matter? Abstract
Steven D. Passik, PhD, Lynn Webster, MD
 
Vol 9, No 1 (2013): January/February Review article. Pharmacokinetic evaluation of hydrocodone/acetaminophen for pain management Abstract
Aarti Singla, MD, Paul Sloan, MD
 
Vol 12, No 4 (2016): July/August Review of perioperative pain management of opioid-dependent patients Abstract
Nalini Vadivelu, MD, Sukanya Mitra, MD, MAMS, Alice M. Kai, BA, Gopal Kodumudi, MS, Karina Gritsenko, MD
 
Vol 17, No 7 (2021): Special Issue - “Buprenorphine: Clinical and Public Policy Implications" Review of the adaptations in opioid agonist treatment during the COVID-19 pandemic: Focus on buprenorphine-based treatment Abstract
Abhishek Ghosh, MD, DM, Chandrima Naskar, MD, Fazl-e Roub, MD, DM, Debasish Basu, MD, DNB, MAMS
 
Vol 12, No 5 (2016): September/October Rhode Island Board of Medical Licensure and Discipline: Illustration of the disciplinary process as it pertains to cases involving opioid prescribing Abstract
James V. McDonald, MD, MPH
 
Vol 8, No 5 (2012): September/October Risk assessment and counseling behaviors of healthcare professionals managing patients with chronic pain: A national multifaceted assessment of physicians, pharmacists, and their patients Abstract
Gregory D. Salinas, PhD, Debi Susalka, B. Stephen Burton, MS, Nancy Roepke, MBA, Kimberly Evanyo, David Biondi, DO, Susan Nicholson, MD
 
Vol 8, No 6 (2012): November/December Risk factors for drug diversion in a pain clinic patient population Abstract
Mary Jean Walker, DNP, Lynn R. Webster, MD
 
Vol 12, No 3 (2016): May/June Risk factors for opioid misuse in adolescents and young adults with focus on oncology setting Abstract
Kelly R. Peck, MA, Jennifer Harman Ehrentraut, PhD, Doralina L. Anghelescu, MD
 
Vol 16, No 1 (2020): January/February Risk of chronic opioid use in older persons with pre-existing anxiety Abstract
Anna K. Moffat, PhD, Nicole L. Pratt, PhD, Mhairi Kerr, MSc, Lisa M. Kalisch Ellett, PhD, Elizabeth E. Roughead, PhD
 
Vol 3, No 4 (2007): July/August Roadblock on the health IT superhighway: E-prescribing and the controlled substances act Abstract
Kate L. Lapane, PhD, Brian J. Quilliam, PhD, David D. Dore, PharmD
 
Vol 7, No 5 (2011): September/October Role of codeine in palliative care Abstract
Eric Prommer, MD
 
Vol 7, No 4 (2011): July/August Role of codeine in palliative care Abstract
Eric Prommer, MD
 
Vol 1, No 4 (2005): September/October Role of gabapentin in postoperative pain Abstract   PDF
Alparslan Turan, MD
 
Vol 4, No 3 (2008): May/June Role of patient-based health status outcome measurements in opioid management for low back pain Abstract
Vinod K. Podichetty, MD, MS, Eric S. Varley, DO, Michelle Secic, MS
 
501 - 750 of 950 Items << < 1 2 3 4 > >>